Hypothesis / aims of study
Post-prostatectomy incontinence (PPI) is a distressing complication following radical prostatectomy, significantly impacting quality of life and increasing dependency on daily activities. The etiology of PPI can be multifactorial, dependent on patient characteristics, lower urinary tract function, or surgical factors. Functional pelvic electrical stimulation (FPES) stands out as a treatment modality for urinary incontinence and is the sole conservative management covered by Taiwan National Health Insurance. This study aimed to evaluate the effectiveness of FPES in managing PPI.
Study design, materials and methods
Patients who underwent robotic-assisted nerve-sparing radical prostatectomy between 2019 and 2023 and experienced complications of post-prostatectomy incontinence (PPI), and did not respond to behavioral and physical therapies, as well as pharmacological management such as Solifenacin, were included in the study. Each patient received functional pelvic floor electrical stimulation (FPES) twice weekly for one course. The electrical stimulation patch was positioned over the perineum, spanning from the base of the scrotum to the anus. The stimulation treatment lasts approximately 20 minutes, featuring a phase duration of 300 µs, a frequency of 50-80 Hz, and an interval time of 15 seconds. Throughout the treatment process, we also educate patients on correctly performing pelvic floor muscle training at home. The assessment and quantification of incontinence symptoms were conducted using the Urinary Distress Inventory, Short Form (UDI-6), Overactive Bladder Symptom Score (OABSS), and Incontinence Impact Questionnaire, Short Form (IIQ-7). Measurements were taken before and after three courses of FPES treatment. Pre-FPES and post-FPES scores were collected and analyzed using paired sample t-tests.
Interpretation of results
Based on the statistically significant decrease in the total score of the questionnaire, it can be inferred that the patients subjectively perceive an improvement in urinary symptoms and overall quality of life. The patient experienced no complications during the treatment and subsequent follow-up, confirming the safety of the procedure.